is now available and shipping to customers with broad compatibility across Illumina's NGS platform portfolio, including NextSeq 1000/2000, NovaSeq 6000, and NovaSeq X. The single-cell sample prep ...

After yesterday’s announcement, Illumina shares edged up 0.3%, closing at $139.08. The company is heavily investing in innovations to make the NovaSeq platform stronger and more versatile ...

Illumina (ILMN) announced a series of updates to its NovaSeq X Series ... TipRanks' multi-award winning platform ranks financial experts based on measured performance and the accuracy of their ...

He noted significant advancements in operational excellence, customer collaboration, and innovation, including the NovaSeq X transition and new partnerships. Illumina reported Q4 revenue of $1.1 ...